These Analysts Boost Their Forecasts On Precigen Following Q4 Results

Group 1 - Precigen, Inc. reported a quarterly loss of 1 cent per share, beating the analyst consensus estimate of losses of 8 cents per share [1] - The company reported quarterly sales of $4.565 million, missing the analyst consensus estimate of $8.286 million [1] - Following the earnings announcement, Precigen shares fell 3.5% to trade at $3.84 [1] Group 2 - HC Wainwright & Co. analyst maintained a Buy rating on Precigen and raised the price target from $9 to $10 [2] - Citizens analyst maintained the stock with a Market Outperform rating and raised the price target from $8 to $9 [2]